Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients.

AIM To study the expression of cyclooxygenase-2 (COX-2) in human gastric cancer tissues and their paired adjacent mucosa, as well as mucosa from gastric antrum and corpus of the first-degree relatives of the recruited cancer patients. METHODS The expression of COX-2 mRNA in 38 patients with gastric cancer and their 29 first-degree relatives and 18 healthy controls was assessed by the real time RT-PCR. The expression of COX-2 protein was determined by Western blot. RESULTS A marked increase in COX-2 mRNA expression was found in 20 of 37 (54%) cancerous tissues compared to their respective paired normal mucosa (P<0.001). Interestingly, increased COX-2 mRNA expression was also found in mucosa of the corpus (6/29) and antrum (13/29) of their first-degree relatives. Increased COX-2 mRNA expression was more frequently observed in the antrum biopsies from cancer patients than in the antrum biopsies from healthy controls (P<0.05). In addition, 3 of 23 (13%) patients with atrophic mucosa and 6 of 35 (17%) patients with intestinal metaplasia showed increased COX-2 mRNA expression. Furthermore, COX-2 expression increased in H pylori-positive tissues, especially in antrum mucosa. CONCLUSION Increased COX-2 expression is involved in gastric carcinogenesis, and may be necessary for maintenance of the malignant phenotype and contribute to Helicobacter pylori-associated malignant transformation.

[1]  G. Glober,et al.  Intestinal metaplasia of the stomach in Hawaii and Japan , 1978, The American Journal of Digestive Diseases.

[2]  P. Malfertheiner,et al.  α-Catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives , 2000, Gut.

[3]  Jun Yu,et al.  Frequency of TPR‐MET rearrangement in patients with gastric carcinoma and in first‐degree relatives , 2000, Cancer.

[4]  T. Fahey,et al.  Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.

[5]  H. Shiozaki,et al.  Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma , 1999, American Journal of Gastroenterology.

[6]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.

[7]  S. Meltzer,et al.  Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1 , 2006 .

[8]  S. Kargman,et al.  Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours. , 1997, European journal of cancer.

[9]  D. Beall.  Classification and Grading of Gastritis: The Updated Sydney System , 1997 .

[10]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[11]  K. Subbaramaiah,et al.  Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. , 1996, Cancer research.

[12]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[13]  M. Bertagnolli,et al.  Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. , 1996, Cancer research.

[14]  J. Scheiman.  NSAIDs, gastrointestinal injury, and cytoprotection. , 1996, Gastroenterology clinics of North America.

[15]  H. Herschman.  Prostaglandin synthase 2. , 1996, Biochimica et biophysica acta.

[16]  M. Dixon.  Histological responses to Helicobacter pylori infection: gastritis, atrophy and preneoplasia. , 1995, Bailliere's clinical gastroenterology.

[17]  S. Badve,et al.  Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. , 1995, Gut.

[18]  P. Libby,et al.  Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[19]  S. Plummer,et al.  Oxidation and genotoxicity of fecapentaene-12 are potentiated by prostaglandin H synthase. , 1995, Carcinogenesis.

[20]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[21]  D. Graham,et al.  Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. , 1994, Gastrointestinal endoscopy.

[22]  G. Stemmermann,et al.  Helicobacter pylori and gastric cancer , 1993, Journal of gastroenterology and hepatology.

[23]  Brown Ke,et al.  Diagnosis of Helicobacter pylori infection , 1993 .

[24]  D. Peura,et al.  Diagnosis of Helicobacter pylori infection. , 1993, Gastroenterology clinics of North America.

[25]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. la Vecchia,et al.  Family history and the risk of stomach and colorectal cancer , 1992, Cancer.

[27]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[28]  R. Sassatelli,et al.  Familial occurrence of gastric cancer in the 2‐year experience of a population‐based registry , 1990, Cancer.

[29]  D M Parkin,et al.  Estimates of the worldwide frequency of sixteen major cancers in 1980 , 1988, International journal of cancer.

[30]  P. Sipponen,et al.  INTESTINAL METAPLASIA WITH COLONIC‐TYPE SULPHOMUCINS IN THE GASTRIC MUCOSA; ITS ASSOCIATION WITH GASTRIC CARCINOMA , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.